Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
Biden’s CUREIT initiative aims to develop a toolbox of technologies to fight cancer, autoimmune disorders and infectious diseases.
The days of Americans paying far more for prescription drugs are ending, said President Biden.
Some insurers bypass hospital pharmacies and physician offices, shifting who gets to buy and bill for medications like chemotherapy drugs.
Several mechanisms may play a role, including persistent virus and ongoing immune dysregulation.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
Novel therapies, improved technologies and a better understanding of the immune system could yield broad dividends.
Transplant recipients, people with advanced HIV and certain people with cancer or autoimmune diseases can get an additional vaccine dose.
Antibodies that mistakenly target the body’s own immune-system proteins may account for about 20% of COVID-19 deaths.
Trial also will test pausing immunosuppressive medication to improve antibody response.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
Screening patients for autoantibodies against interferons could help predict which patients are more likely to become very sick.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.